交易中 07-06 11:28:02 美东时间
-0.019
-0.15%
Ladenburg Thalmann analyst Floris Van Dijkum maintains Diamondrock Hospitality (NASDAQ:DRH) with a Buy and raises the price target from $13 to $14.
06-19 03:10
DiamondRock Hospitality updates financial calendar with second-quarter earnings release, conference call DiamondRock Hospitality will release second-quarter 2026 results on July 30, 2026, following the market close. A conference call is scheduled for July 31, 2026 at 10:00 a.m. ET to discuss the res
06-18 19:30
DiamondRock Hospitality Director Kathleen Merrill sells 20,000 shares for $237,600 DiamondRock Hospitality’s director Kathleen Merrill sold 20,000 common shares on June 12, 2026 at USD 11.88. Her direct stake fell to 84,335 shares following the transaction. Disclaimer: This news brief was created by
06-16 18:20
The 2026 FIFA World Cup could provide a temporary boost to a range of consumer, media, and gaming stocks, with hotels, restaurants, broadcasters, and sports-betting operators among the biggest potenti...
06-03 18:48
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从13.5美元升至14美元;BTIG:维持Jade Biosciences"买入"评级,目标价从39美元升至74美元
06-02 16:25
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
Truist Securities analyst Patrick Scholes maintains Diamondrock Hospitality (NASDAQ:DRH) with a Buy and raises the price target from $11 to $12.
05-27 00:46
Investors Should Know: Rate-sensitive dividend stocks are drawing renewed attention as investors weigh the balance between income reliability and balance-sheet strength in a high-rate, elevated-inflat...
05-18 22:33
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36